PLoS ONE (Jan 2022)

The changes of electroencephalography in mountaineers on Mount Jade, Taiwan: An observational study.

  • Kuo-Song Chang,
  • Yu-Hui Chiu,
  • Wei-Fong Kao,
  • Cheryl C H Yang,
  • Chorng-Kuang How,
  • Yen-Kuang Lin,
  • Yuh-Shyan Hwang,
  • Ding-Kuo Chien,
  • Ming-Kun Huang,
  • Terry B J Kuo

DOI
https://doi.org/10.1371/journal.pone.0275870
Journal volume & issue
Vol. 17, no. 11
p. e0275870

Abstract

Read online

BackgroundThe diagnosis of acute mountain sickness, which lacks a reliable and objective diagnostic tool, still depends on the clinical symptoms and signs and remains a major threat and unpredictable disease affecting millions of mountaineers.ObjectivesTo record electroencephalography signals with small, convenient, wireless equipment and to test whether electroencephalography parameters, which are more sensitive and reliable markers, could predict the symptoms of acute mountain sickness.MethodsTwenty-five participants were enrolled and separated into two groups to climb Mount Jade in Taiwan. We collected electrocardiography signals and arterial oxygen saturation data at ground, moderate (2,400 m), and high altitude (3,400 m). A spectral analysis of the electrocardiography was performed to assess the study subjects' electroencephalography activity at different frequencies (α, β, θ, δ) and the mean power frequency of electrocardiography. The clinical symptoms and Lake Louise Acute Mountain Sickness scores of the subjects were recorded for comparison.ResultsA significant change in the δ power of electroencephalography was recorded in subjects ascending from the ground to a high altitude of 3,400 m in a 4-day itinerary. In addition, between the two groups of subjects with and without acute mountain sickness (Lake Louise Acute Mountain Sickness scores ConclusionAt moderate altitude, the δ power increase of electroencephalography at the P4 electrode could be a predictor of acute mountain sickness symptoms before ascending to high altitude. Thus, electroencephalography had the potential to identify the risk of acute mountain sickness.